J45.21
Mild intermittent asthma with (acute) exacerbation
Mild intermittent asthma with acute exacerbation refers to a clinical state where a patient, who typically experiences asthma symptoms fewer than twice per week and nighttime awakenings fewer than twice per month, undergoes a sudden increase in the severity of respiratory symptoms. During an exacerbation, also known as an asthma attack, the patient experiences increased airway inflammation and bronchoconstriction that deviates from their baseline stable state. This requires a prompt change in therapeutic management, usually involving the administration of short-acting beta-agonists (SABA) or systemic corticosteroids to prevent progression to status asthmaticus or respiratory failure. Despite the 'mild intermittent' baseline classification, the exacerbation itself represents a high-risk event that requires clinical assessment of airway patency and ventilation.
Clinical Symptoms
- Acute shortness of breath
- Wheezing on expiration (and occasionally inspiration)
- Chest tightness or pressure
- Productive or non-productive cough, often worse at night
- Tachypnea (rapid breathing)
- Tachycardia (rapid heart rate)
- Use of accessory muscles for respiration
- Decreased peak expiratory flow rate (PEFR)
- Anxiety or panic associated with respiratory distress
- Difficulty speaking in full sentences
Common Causes
- Viral upper respiratory tract infections (most common trigger)
- Exposure to allergens such as pollen, mold, dust mites, or animal dander
- Inhalation of environmental irritants like tobacco smoke, wood smoke, or air pollution
- Exercise-induced bronchospasm
- Exposure to cold or dry air
- Occupational chemical exposures or strong odors
- Gastroesophageal reflux disease (GERD)
- Psychological stress or emotional distress
- Hypersensitivity to certain medications (e.g., aspirin or NSAIDs)
Documentation & Coding Tips
Distinguish Intermittent from Persistent Status
Example: Patient presents with increased cough and wheezing over the last 2 days. Baseline history shows daytime symptoms occur 1 day per week and nighttime awakenings occur 1 time per month, which confirms a baseline of mild intermittent asthma. Currently experiencing an acute flare-up triggered by viral URI. Plan: SABA via nebulizer in clinic and 5-day course of oral corticosteroids. Billing focus: Baseline severity must be documented alongside the acute status. Risk adjustment: HCC 112 is triggered by the exacerbation status in several risk models.
Billing Focus: Severity classification (intermittent vs. persistent) and current status (exacerbation).
Document Objective Triggers and Frequency
Example: The patient, with a known history of mild intermittent asthma, presents with an acute exacerbation after exposure to high pollen counts. Symptoms include expiratory wheezing and a peak flow of 250 L/min (baseline 380 L/min). Patient typically requires albuterol less than twice weekly at baseline. This encounter focuses on the acute exacerbation management. Billing focus: Identification of environmental triggers. Risk adjustment: Documentation of severity and trigger supports medical necessity for higher-level E/M services.
Billing Focus: Inclusion of environmental triggers and baseline medication frequency.
Clarify the Absence of Status Asthmaticus
Example: Patient seen for acute exacerbation of mild intermittent asthma. Symptoms are responsive to a single nebulizer treatment of albuterol/ipratropium in the office. Oxygen saturation is 96 percent on room air. Status asthmaticus is ruled out as the patient is not in respiratory failure and is responding to standard therapy. Billing focus: Explicitly stating with exacerbation and excluding status asthmaticus avoids upcoding. Risk adjustment: Differentiates acute exacerbation from the more severe status asthmaticus coding.
Billing Focus: Specific exclusion of status asthmaticus when clinical criteria are not met.
Document Tobacco Exposure or Use
Example: Mild intermittent asthma with acute exacerbation. Patient is a non-smoker but reports significant second-hand smoke exposure in the home. Managed today with SABA and oral steroids. Cessation counseling provided to the parent. Billing focus: Use secondary codes for tobacco smoke exposure (Z77.22) to provide a complete clinical picture. Risk adjustment: Comorbidities like smoke exposure can increase the complexity of managing respiratory conditions.
Billing Focus: Linkage between asthma exacerbation and environmental tobacco smoke exposure.
Specific Reporting of Rescue Inhaler Use
Example: Patient with mild intermittent asthma presents with exacerbation. Baseline SABA use is 1 day per week. Over the last 24 hours, usage increased to every 4 hours. Physical exam reveals bilateral wheezing and accessory muscle use. Billing focus: Documenting the change from baseline SABA use to current acute use supports the exacerbation diagnosis. Risk adjustment: Demonstrates the severity of the acute episode relative to the patient's baseline chronic state.
Billing Focus: Contrast between baseline rescue inhaler usage and current acute usage.
Relevant CPT Codes
-
99213 - Office Outpatient Visit Established
Commonly used for a follow-up or straightforward management of an acute asthma flare.
-
99214 - Office Outpatient Visit Established
Used when the exacerbation is more complex or requires systemic steroids and multiple treatments.
-
94010 - Spirometry
Objective measurement of lung function to assess the severity of the exacerbation.
-
94060 - Bronchodilation Responsiveness
Determines the reversibility of the airway obstruction during an acute event.
-
94640 - Pressurized Inhalation Treatment
Code for administering a nebulizer treatment in the office during an exacerbation.
-
94664 - Inhalation Instruction
Necessary when a patient's inhaler technique needs correction during an exacerbation event.
-
99283 - Emergency Department Visit
Appropriate for an ER visit for an asthma flare that is not life-threatening but requires urgent intervention.
-
99203 - Office Outpatient Visit New
Used for a new patient presenting with their first recognized asthma exacerbation.
-
J7611 - Albuterol Inhalation Solution
HCPCS code for the medication used during an office nebulizer treatment.
-
82784 - Gammaglobulin IgE
Laboratory test to identify allergic components that may be triggering the exacerbation.
Related Diagnoses
- J45.20 - Mild intermittent asthma, uncomplicated
- J45.22 - Mild intermittent asthma with status asthmaticus
- J45.31 - Mild persistent asthma with (acute) exacerbation
- J45.901 - Unspecified asthma with (acute) exacerbation
- J30.1 - Allergic rhinitis due to pollen
- J20.9 - Acute bronchitis, unspecified
- R06.2 - Wheezing
- Z77.22 - Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)
- J45.991 - Cough variant asthma
- J45.41 - Moderate persistent asthma with (acute) exacerbation
- J45.51 - Severe persistent asthma with (acute) exacerbation
- J01.90 - Acute maxillary sinusitis, unspecified